Home > Signaling Pathways>Neuronal Signaling>Calcium Channel>Lacidipine (GX-1048, GR-43659X, SN-305, Lacipil, Motens)
Lacidipine (GX-1048, GR-43659X, SN-305, Lacipil, Motens)

This product is for research use only, not for human use. We do not sell to patients.

Lacidipine (GX-1048, GR-43659X, SN-305, Lacipil, Motens)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
500mg$430Check With Us
1g$700Check With Us
5g$2000Check With Us

Cat #: V1199 CAS #: 103890-78-4 Purity ≥ 98%

Description: Lacidipine (GX-1048, GR-43659X, SN-305; GX1048, GR43659X, SN305; Caldine, Lacimen, Lacipil, Midotens, Motens) is a potent and 3rd-generation L-type CCB (calcium channel blocker) that has been approved in 1990s for treating high blood pressure.

References: Cristofori P, et al. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. J Hypertens. 2000 Oct;18(10):1429-36. 

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)455.54
Molecular FormulaC26H33NO6
CAS No.103890-78-4
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 91 mg/mL (199.7 mM)r
Water: <1 mg/mLr
Ethanol: 22 mg/mL (48.3 mM)
Solubility In VivoNA
SynonymsGX-1048, GR-43659X, SN-305; GX 1048, GR 43659X, SN 305; GX1048, GR43659X, SN305; Lacipil, Motens
ProtocolIn VivoLacidipine (0.3, 1.0, 3.0 mg/kg; p.o.; single daily for 10 weeks) shows anti-atherogenic effects in the apoE-deficient mouse, and reduces plasma endothelin concentrations
Animal modelFemale C57BL/6 mice (Homozygous; apoE-deficient; atherosclerosis model)
Dosages0.3, 1.0, 3.0 mg/kg
AdministrationOral gavage; single daily for 10 weeks.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.1952 mL10.9760 mL21.9520 mL43.9039 mL
5mM0.4390 mL2.1952 mL4.3904 mL8.7808 mL
10mM0.2195 mL1.0976 mL2.1952 mL4.3904 mL
20mM0.1098 mL0.5488 mL1.0976 mL2.1952 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.